64 related articles for article (PubMed ID: 24589829)
1. Risk assessment in liver transplantation for hepatocellular carcinoma: long-term follow-up of a two-centre experience.
Wehrle CJ; Raj R; Maspero M; Satish S; Eghtesad B; Pita A; Kim J; Khalil M; Calderon E; Orabi D; Zervos B; Modaresi Esfeh J; Whitsett Linganna M; Diago-Uso T; Fujiki M; Quintini C; Kwon CD; Miller C; Pinna A; Aucejo F; Hashimoto K; Schlegel A
Int J Surg; 2024 May; 110(5):2818-2831. PubMed ID: 38241354
[TBL] [Abstract][Full Text] [Related]
2. "Metroticket" predictor for assessing liver transplantation to treat hepatocellular carcinoma: a single-center analysis in mainland China.
Lei JY; Wang WT; Yan LN
World J Gastroenterol; 2013 Nov; 19(44):8093-8. PubMed ID: 24307805
[TBL] [Abstract][Full Text] [Related]
3. Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective study.
Lin KY; Zhang JX; Lin ZW; Chen QJ; Luo LP; Chen JH; Wang K; Tai S; Zhang ZB; Wang SF; Li JD; Wang K; Zheng L; Zheng SM; Wu MM; Lin KC; Yang T; Zeng YY
Front Immunol; 2024; 15():1308543. PubMed ID: 38433845
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of
Luo XY; Chang KW; Ye N; Gao CH; Zhu QB; Liu JP; Zhou X; Zheng SS; Yang Z
Front Med (Lausanne); 2024; 11():1380750. PubMed ID: 38799149
[TBL] [Abstract][Full Text] [Related]
5. Long-term prognosis of patients with gallbladder carcinoma after curative-intent resection based on changes in the ratio of carbohydrate antigen 19-9 to total bilirubin (CA19-9/TB): a multicenter retrospective cohort study.
Li XL; Liu ZP; Su XX; Gong Y; Yang YS; Zhao XL; Li ZM; Ding JJ; Zhu Y; Yin DL; Yu C; Zhou JX; Zhang D; Ding R; Chen W; Cheng Y; Yue P; Wang ZR; Zhang YQ; Jiang Y; Yin XY; Bai J; Dai HS; Lau WY; Chen ZY;
Int J Surg; 2024 Apr; ():. PubMed ID: 38626431
[TBL] [Abstract][Full Text] [Related]
6. [Liver transplantation for treatment of nonresectable primary and secondary liver malignancies : Hepatocellular and cholangiocellular carcinomas and colorectal liver metastases].
Guba M; Werner J
Chirurgie (Heidelb); 2024 Apr; 95(4):268-273. PubMed ID: 38329517
[TBL] [Abstract][Full Text] [Related]
7. Extrahepatic metastasis risk of hepatocellular carcinoma based on α-fetoprotein and tumor staging parameters at cross-sectional imaging.
Yokoo T; Patel AD; Lev-Cohain N; Singal AG; Yopp AC; Pedrosa I
Cancer Manag Res; 2017; 9():503-511. PubMed ID: 29081671
[TBL] [Abstract][Full Text] [Related]
8. The Predictive Value of CA-125 and Hb for Ocular Metastasis in Hepatocellular Carcinoma Patients.
Xiong X; Rong R; Tang LY; Sun T; Pan YC; Shu HY; Zhang LJ; Ge QM; Liang RB; Shao Y
Cancer Manag Res; 2022; 14():3405-3415. PubMed ID: 36504761
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of inflammation-immunity-nutrition score in patients with hepatocellular carcinoma treated with anti-PD-1 therapy.
Zhang Z; Liang Y; Zhong D; Dai Z; Shang J; Lai C; Zou H; Yao Y; Feng T; Huang X
J Clin Lab Anal; 2022 May; 36(5):e24336. PubMed ID: 35312116
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular cancer selection systems and liver transplantation: from the tower of babel to an ideal comprehensive score.
Lerut J; Foguenne M; Lai Q
Updates Surg; 2021 Oct; 73(5):1599-1614. PubMed ID: 34003479
[TBL] [Abstract][Full Text] [Related]
11. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.
Xiang H; Long L; Yao Y; Fang Z; Zhang Z; Zhang Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819830751. PubMed ID: 30862264
[TBL] [Abstract][Full Text] [Related]
12. Nomogram predicting pulmonary metastasis of hepatocellular carcinoma after liver transplantation.
Huang LF; Wan P; Xu DW; Jeong S; Feng MX; Zhang JJ; Xia Q
Oncotarget; 2018 Jan; 9(2):2425-2434. PubMed ID: 29416782
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Carbohydrate Antigen 19-9: Its Neglected Role in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
Lu LH; Zhang YF; Wei W; Shi M; Guo RP
J Gastrointest Surg; 2017 Dec; 21(12):2025-2032. PubMed ID: 28840443
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review.
Xu DW; Wan P; Xia Q
World J Gastroenterol; 2016 Mar; 22(12):3325-34. PubMed ID: 27022214
[TBL] [Abstract][Full Text] [Related]
15. Association of Histone Methyltransferase G9a and Overall Survival After Liver Resection of Patients With Hepatocellular Carcinoma With a Median Observation of 40 Months.
Bai K; Cao Y; Huang C; Chen J; Zhang X; Jiang Y
Medicine (Baltimore); 2016 Jan; 95(2):e2493. PubMed ID: 26765460
[TBL] [Abstract][Full Text] [Related]
16. Elevated CA19-9 Is Associated With Increased Mortality In A Prospective Cohort Of Hepatocellular Carcinoma Patients.
Hsu CC; Goyal A; Iuga A; Krishnamoorthy S; Lee V; Verna EC; Wang S; Chen FN; Rodriguez R; Emond J; Berk P; Lefkowitch J; Dove L; Brown RS; Siegel AB
Clin Transl Gastroenterol; 2015 Feb; 6(2):e74. PubMed ID: 25651978
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of preoperative α-fetoprotein and CA19-9 predict survival of hepatic carcinoma patients after liver transplantation.
Wan P; Zhang J; Long X; Li Q; Xu N; Zhang M; Chen X; Han L; Xia Q
Eur J Gastroenterol Hepatol; 2014 May; 26(5):553-61. PubMed ID: 24589829
[TBL] [Abstract][Full Text] [Related]
18. α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.
Zhang Q; Shang L; Zang Y; Chen X; Zhang L; Wang Y; Wang L; Liu Y; Mao S; Shen Z
Eur J Gastroenterol Hepatol; 2014 May; 26(5):544-52. PubMed ID: 24614696
[TBL] [Abstract][Full Text] [Related]
19. AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.
Yaprak O; Akyildiz M; Dayangac M; Demirbas BT; Guler N; Dogusoy GB; Yuzer Y; Tokat Y
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):256-61. PubMed ID: 22672818
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
